Tomas Jan Heyman

Tomas Jan Heyman

Director/Miembro de la Junta en XILIO THERAPEUTICS, INC. .

Fortuna: - $ al 30/04/2024

68 años
Health Technology
Commercial Services
Consumer Services

Origen de la red de primer grado Tomas Jan Heyman.

EntidadTipo de entidadIndustria
Public Company Pharmaceuticals: Major 357
Public Company Biotechnology 28
Public Company Pharmaceuticals: Major 25
Public Company Pharmaceuticals: Major 25
Public Company Pharmaceuticals: Major 24
Public Company Pharmaceuticals: Major 19
Public Company Pharmaceuticals: Major 18
17
Non-Profit Organization Miscellaneous Commercial Services 17
8
Subsidiary Pharmaceuticals: Major 8
3
Holding Company Miscellaneous Commercial Services 3

Gráfico Empresas conectadas de segundo grado

Relaciones con varias empresas

Empresas conectadas a Tomas Jan Heyman a través de su red personal

EmpresaSectorPersonas relacionadasPuesto principal
Biotechnology

Corazon Sanders

Patrick Haley

Chief Administrative Officer

Corporate Officer/Principal

GILEAD SCIENCES, INC. Biotechnology

Susan T. Hubbard

Andrew Cheng

Jeffrey Hessekiel

Yuan Xu

Patrick Lamy

Investor Relations Contact

Chief Tech/Sci/R&D Officer

Compliance Officer

Corporate Officer/Principal

Corporate Officer/Principal

ELI LILLY AND COMPANY Pharmaceuticals: Major

John Johnson

Sara Bonstein

Mythili Koneru

Lori Macomber

President

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

PFIZER, INC. Pharmaceuticals: Major

Christine Regan Lindenboom

Arindam Bose

Timothy Rolph

David Hering

Public Communications Contact

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

BIOGEN INC. Pharmaceuticals: Major

Stelios Papadopoulos

Paul Clancy

Maria Freire

Chairman

Director of Finance/CFO

Director/Board Member

COVANCE INC. Pharmaceuticals: Major

Joseph Scodari

Sandra Helton

Director/Board Member

Director/Board Member

CITIGROUP INC. Major Banks

Anne Mulcahy

William White

Director/Board Member

Corporate Officer/Principal

Medical Specialties

William Duke

Christina Rossi

Director of Finance/CFO

Corporate Officer/Principal

Miscellaneous Commercial Services

Joseph Scodari

John Johnson

Julie Smith

Director/Board Member

Director/Board Member

Corporate Officer/Principal

AILERON THERAPEUTICS, INC. Pharmaceuticals: Major

Seth Harrison

Mike Diem

Chairman

Director/Board Member

Biotechnology

Tillman Gerngross

Marc Elia

Chairman

Director/Board Member

The Trustees of Columbia University in The City of New York College/University

Seth Harrison

Ying Huang

William White

Doctorate Degree

Doctorate Degree

Graduate Degree

College/University

Mark McClellan

Jane Henderson

Patrick J. Casey

Fang Liang Zhang

Jeffrey Hessekiel

Patrick Haley

Christina Rossi

Corporate Officer/Principal

Undergraduate Degree

Corporate Officer/Principal

Doctorate Degree

Undergraduate Degree

Undergraduate Degree

Undergraduate Degree

College/University

Alan Garber

Michael Morrissey

William White

Corporate Officer/Principal

Doctorate Degree

Graduate Degree

Stanford University College/University

Alan Garber

Mark McClellan

Robert Ross

Doctorate Degree

Corporate Officer/Principal

Undergraduate Degree

Hospital/Nursing Management

Sandra Helton

William Perez

Director/Board Member

Director/Board Member

Pharmaceuticals: Major

Russell C. Deyo

Joseph Scodari

John Johnson

Director/Board Member

Chairman

Private Equity Investor

University of Cambridge College/University

Peter Lamb

Stefan Krauss

Undergraduate Degree

Doctorate Degree

Investment Managers

Kevin Bitterman

Mark Iwicki

René Russo

Private Equity Investor

Consultant / Advisor

Consultant / Advisor

Miscellaneous Commercial Services

Michael Marino

Christopher Frankenfield

Corporate Officer/Principal

Corporate Officer/Principal

Massachusetts Institute of Technology College/University

Bill Doyle

Mark McClellan

Christopher Burns

Undergraduate Degree

Doctorate Degree

Doctorate Degree

Rutgers State University of New Jersey College/University

Robert E. Campbell

Sherilyn McCoy

Kevin Bitterman

Mike Diem

Director/Board Member

Corporate Officer/Principal

Undergraduate Degree

Undergraduate Degree

The University of Chicago College/University

Xiao Hui Ji

Mythili Koneru

Masters Business Admin

Undergraduate Degree

College/University

William Perez

Julie Smith

David Hering

Director/Board Member

Undergraduate Degree

Undergraduate Degree

The Pennsylvania State University College/University

Matthew Stuckley

Lori Macomber

Paul Spence

Undergraduate Degree

Undergraduate Degree

Undergraduate Degree

Princeton University College/University

Sherilyn McCoy

Seth Harrison

William White

Graduate Degree

Undergraduate Degree

Undergraduate Degree

Villanova University College/University

Robert J. Darretta

Michael Marino

Paul Spence

Undergraduate Degree

Undergraduate Degree

Masters Business Admin

Services to the Health Industry

Anne Mulcahy

Peter Fasolo

Director/Board Member

Director/Board Member

US Department of Defense (District of Columbia) Sovereign

Robert E. Campbell

George Poste

Corporate Officer/Principal

Corporate Officer/Principal

Nanjing University College/University

Fang Liang Zhang

Yuan Xu

Graduate Degree

Undergraduate Degree

Katholieke Universiteit Leuven College/University

Brigitte Boone

Ann Caluwaerts

Luc van den Hove

Graduate Degree

Graduate Degree

Doctorate Degree

Robert Wood Johnson Medical School College/University

Mike Diem

William Hait

Mythili Koneru

Doctorate Degree

Corporate Officer/Principal

Doctorate Degree

Investment Managers

Seth Harrison

Timothy Rolph

Jonathan Young

Founder

Corporate Officer/Principal

Corporate Officer/Principal

Miscellaneous Commercial Services

Alan Garber

Michael Johns

Mark McClellan

Maria Freire

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

NOVOCURE LIMITED Medical Specialties

Bill Doyle

Wilhelmus Groenhuysen

Sherilyn McCoy

James T. Lenehan

Chairman

Chief Operating Officer

Director/Board Member

Director/Board Member

Pharmaceuticals: Major

Bill Doyle

Joseph Scodari

Sandra Helton

Ramy Mahmoud

Catherine Owen

Director/Board Member

Chairman

Director/Board Member

President

Director/Board Member

Harvard Medical School College/University

Alan Garber

Kevin Bitterman

Robert Ross

Kyle Dempsey

Corporate Officer/Principal

Doctorate Degree

Graduate Degree

Doctorate Degree

Harvard Business School College/University

Bill Doyle

Christina Rossi

Kyle Dempsey

David Hering

Masters Business Admin

Masters Business Admin

Masters Business Admin

Masters Business Admin

Harvard Kennedy School of Government College/University

Alan Garber

Mark McClellan

Corporate Officer/Principal

Graduate Degree

Medical Specialties

Seth Harrison

Jonathan Young

Chairman

General Counsel

Biotechnology

Fang Liang Zhang

Ye Wang

Chief Executive Officer

Founder

GENSCRIPT BIOTECH CORPORATION Biotechnology

Fang Liang Zhang

Ye Wang

Director/Board Member

Founder

The Wharton School of the University of Pennsylvania College/University

Corazon Sanders

Daniel Curran

Doctorate Degree

Masters Business Admin

Internet Retail

Corazon Sanders

Judy Chou

Director/Board Member

Chief Executive Officer

BLUEPRINT MEDICINES CORPORATION Biotechnology

Christina Rossi

Christopher Frankenfield

Chief Operating Officer

General Counsel

Harvard T.H. Chan School of Public Health College/University

Alan Garber

Ramy Mahmoud

Corporate Officer/Principal

Graduate Degree

VERA THERAPEUTICS, INC. Biotechnology

Michael Morrissey

Andrew Cheng

Chairman

Director/Board Member

BRAEBURN INC. Miscellaneous Commercial Services

Seth Harrison

Jonathan Young

Chairman

Corporate Officer/Principal

Estadísticas

Internacional

Estados Unidos 44
Reino Unido 3
China 3
Bélgica 2

Sectorial

Consumer Services 20
Health Technology 19
Finance 5
Commercial Services 5
Health Services 3

Operativa

Director/Board Member 594
Corporate Officer/Principal 240
Independent Dir/Board Member 160
Chairman 122
Undergraduate Degree 78
-40% Oferta por Tiempo Limitado: Nuestras suscripciones le guían hacia las mejores inversiones del mañana.
APROVÉCHELO AHORA